<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We recently demonstrated that oridonin could induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and senescence of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells in vitro and in vivo </plain></SENT>
<SENT sid="1" pm="."><plain>However, the underlying mechanism remains unknown </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, the involvement of reactive oxygen species in oridonin-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> and senescence was investigated in <z:mp ids='MP_0009314'>colon adenocarcinoma</z:mp>-derived SW1116 cells </plain></SENT>
<SENT sid="3" pm="."><plain>Oridonin increased intracellular <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> levels and reduced the <z:chebi fb="0" ids="16856">glutathione</z:chebi> content in a dose-dependent manner </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="28939">N-acetylcysteine</z:chebi>, a reactive oxygen species scavenger, not only blocked the oridonin-induced increase in <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> and <z:chebi fb="0" ids="16856">glutathione</z:chebi> <z:mpath ids='MPATH_63'>depletion</z:mpath>, but also blocked <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and senescence induced by oridonin, as evidenced by the decrease in Annexin V and senescence-associated Î²-galactosidase- positive cells and the inhibition of oridonin-induced upregulation of p53 and p16 and downregulation of c-Myc </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, exogenous catalase could inhibit the increase in <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by oridonin, but not the <z:chebi fb="0" ids="16856">glutathione</z:chebi> <z:mpath ids='MPATH_63'>depletion</z:mpath> and senescence </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, <z:chebi fb="0" ids="15033">thioredoxin</z:chebi> reductase (TrxR) activity was reduced by oridonin in vitro and in cells, which may cause the increase in <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, the increase in <z:chebi fb="17" ids="16240">hydrogen peroxide</z:chebi> and <z:chebi fb="0" ids="16856">glutathione</z:chebi> <z:mpath ids='MPATH_63'>depletion</z:mpath> account for oridonin-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and senescence in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells, and TrxR inhibition is involved in this process </plain></SENT>
<SENT sid="8" pm="."><plain>Given the importance of TrxR as a novel <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> target in <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, oridonin would be a promising clinical candidate </plain></SENT>
<SENT sid="9" pm="."><plain>The mechanism of oridonin-induced inhibition of TrxR warrants further investigation </plain></SENT>
</text></document>